Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
New England Journal of Medicine · 27.07.2023 · 389 (4) · 297-308
DOI: 10.1056/nejmoa2303208 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 27.07.2023. Verfasst von Julio Rosenstock und 9 weiteren Autor:innen. Beteiligte Einrichtung: From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemia, Hypoglycemic Agents, Insulin Glargine. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Novo Nordisk, Novo Nordisk A/S.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Ce…
ORCID-Profile: Julio Rosenstock, Ildiko Lingvay
Förderung
- Novo Nordisk
- Novo Nordisk A/S
Zitieren
APA
Rosenstock, J., Bain, S. C., Gowda, A., Jódar, E., Liang, B., Lingvay, I., Nishida, T., Trevisan, R., Mosenzon, O., & ONWARDS 1 Trial Investigators (2023). Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. New England Journal of Medicine, 389(4), 297-308. https://doi.org/10.1056/nejmoa2303208
Vancouver
Rosenstock J, Bain SC, Gowda A, Jódar E, Liang B, Lingvay I, et al. Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. New England Journal of Medicine. 2023;389(4):297-308. doi:10.1056/nejmoa2303208
BibTeX
@article{Rosenstock2023,
author = {Rosenstock, Julio and Bain, Stephen C and Gowda, Amoolya and Jódar, Esteban and Liang, Bo and Lingvay, Ildiko and Nishida, Tomoyuki and Trevisan, Roberto and Mosenzon, Ofri and ONWARDS 1 Trial Investigators, ONWARDS 1 Trial Investigators},
title = {Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {4},
pages = {297--308},
doi = {10.1056/nejmoa2303208}
}
EUVIMED